Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-22-014865
Filing Date
2022-04-18
Accepted
2022-04-18 16:14:16
Documents
4
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20002728x1_pre14a.htm PRE 14A 818608
2 logo_atai.jpg GRAPHIC 43339
3 ny20002728x1_pc01.jpg GRAPHIC 680958
4 ny20002728x1_pc02.jpg GRAPHIC 801470
  Complete submission text file 0001140361-22-014865.txt   2920224
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40493 | Film No.: 22832299
SIC: 2834 Pharmaceutical Preparations